- Home
- RNW vs SLNO Comparison
RNW vs SLNO Comparison
Compare RNW & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNW | SLNO |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | RNW | SLNO |
|---|---|---|
| Price | $5.47 | $42.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $7.25 | ★ $110.90 |
| AVG Volume (30 Days) | ★ 2.1M | 1.6M |
| Earning Date | 02-17-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 413.66 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $1,382,164,625.00 | $98,675,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.07 | $155.86 |
| P/E Ratio | $20.64 | ★ N/A |
| Revenue Growth | ★ 46.76 | N/A |
| 52 Week Low | $5.05 | $39.43 |
| 52 Week High | $8.24 | $90.32 |
Technical Indicators
Market Signals| Indicator | RNW | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 33.27 | 34.76 |
| Support Level | $5.35 | $39.43 |
| Resistance Level | $5.57 | $50.88 |
| Average True Range (ATR) | 0.16 | 2.70 |
| MACD | 0.05 | -0.40 |
| Stochastic Oscillator | 22.02 | 24.63 |
Price Performance
Historical ComparisonAbout RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.